Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin H Silver

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annals of Emergency Medicine|June 9, 2005
Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosisSusan M Rohr, Michael W Rich, Kevin H Silver
Journal of General Internal Medicine|June 18, 2013
Stem cell therapy for heart diseaseShannon B Puliafico, Marc S Penn, Kevin H Silver
The Journal of Invasive Cardiology|June 5, 2003
Dual-catheter covered stenting: a novel approach to the treatment of large coronary artery perforationsKevin H Silver, William B Bauman, Kenneth E Berkovitz
European Heart Journal|June 10, 2015
Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trialEugene S Chung, Leslie Miller, Amit N Patel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annals of Emergency Medicine|June 9, 2005
Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosisSusan M Rohr, Michael W Rich, Kevin H Silver
Journal of General Internal Medicine|June 18, 2013
Stem cell therapy for heart diseaseShannon B Puliafico, Marc S Penn, Kevin H Silver
The Journal of Invasive Cardiology|June 5, 2003
Dual-catheter covered stenting: a novel approach to the treatment of large coronary artery perforationsKevin H Silver, William B Bauman, Kenneth E Berkovitz
European Heart Journal|June 10, 2015
Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trialEugene S Chung, Leslie Miller, Amit N Patel, et al.
Pageof 1